A randomized, double blind, parallel, safety and efficacy study of to investigate the effect of Sugammadex on bleeding profile of living donor liver transplantation .
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2017
At a glance
- Drugs Sugammadex (Primary) ; Atropine; Neostigmine
- Indications Neuromuscular blockade; Postoperative haemorrhage
- Focus Therapeutic Use
- 05 Feb 2017 Status changed from not yet recruiting to recruiting.
- 24 Oct 2016 New trial record